STING1 and neoplasm: Because STING has a central role in the regulation of immunity upon infection [25] and has the capability to trigger anti-tumor effects in response to neoantigens and chemo-radiotherapy [26], we decided to investigate its role in the process of MHC-I restricted antigen presentation.